DUBLIN--(BUSINESS WIRE)--The "Atrial Fibrillation Surgery Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global atrial fibrillation surgery market to grow with a CAGR of 13.7% over the forecast period of 2017-2023. The study on atrial fibrillation surgery market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2015 to 2023.
The report on atrial fibrillation surgery market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global atrial fibrillation surgery market over the period of 2015 to 2023.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global atrial fibrillation surgery market over the period of 2015 to 2023. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
- Catheter Ablation Product
- Surgical Ablation Product
- Catheter Ablation Procedures
- Surgical Ablation Procedures
Key Topics Covered
2. Executive Summary
3. Global Atrial Fibrillation Surgery Market Overview
4. Global Atrial Fibrillation Surgery Market by Product
5. Global Atrial Fibrillation Surgery Market by Procedures
6. Global Atrial Fibrillation Surgery Market by Region 2017-2023
7. Company Covered
- Biosense Webster Inc.
- Medtronic Inc.
- St. Jude Medical Inc.
- Boston Scientific Corporation
- Atricure Inc.
- Cardiofocus Inc.
- Ncontact Inc.
- Carima Inc.
- Biotroik SE & Co. KG
- Johnsons & Johnson Ltd
For more information about this report visit https://www.researchandmarkets.com/research/wvvpq2/global_atrial?w=4